Skip to main content
. 2021 Jul 5;125(7):955–965. doi: 10.1038/s41416-021-01471-1

Fig. 1. Study design.

Fig. 1

CIPN chemotherapy-induced peripheral neuropathy, pre assessment point before neurotoxic chemotherapy, post0 assessment point 3 weeks after neurotoxic chemotherapy, post3 assessment point 3 months after post0, post6 assessment point 6 months after post0, R randomisation.